PROGNOSTIC FACTORS FOR BREAST-CANCER - HAVE THEY MET THEIR PROMISE

被引：58

作者：

OSBORNE, CK

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1992年 / 10卷 / 05期

关键词：

D O I：

10.1200/JCO.1992.10.5.679

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：679 / 682

页数：4

相关论文

共 15 条

[1] EBCTC Group, 1992, LANCET, V339, P1
[2] ELLEDGE RM, IN PRESS SEMIN ONCOL
[3] RELATIVE WORTH OF ESTROGEN OR PROGESTERONE-RECEPTOR AND PATHOLOGIC CHARACTERISTICS OF DIFFERENTIATION AS INDICATORS OF PROGNOSIS IN NODE NEGATIVE BREAST-CANCER PATIENTS - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL B-06
FISHER, B
REDMOND, C
FISHER, ER
CAPLAN, R
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) : 1076 - 1087
[4] FISHER ER, 1983, CANCER-AM CANCER SOC, V51, P181, DOI 10.1002/1097-0142(19830115)51:2<181::AID-CNCR2820510202>3.0.CO
[5] 2-A
[6] HUMAN BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF THE C-ERBB-2 ONCOPROTEIN COMPARED WITH EPIDERMAL GROWTH-FACTOR RECEPTOR, DNA PLOIDY, AND CONVENTIONAL PATHOLOGICAL FEATURES
GASPARINI, G
GULLICK, WJ
BEVILACQUA, P
SAINSBURY, JRC
MELI, S
BORACCHI, P
TESTOLIN, A
LAMALFA, G
POZZA, F
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) : 686 - 695
[7] GELLER RB, 1989, CANCER, V64, P629, DOI 10.1002/1097-0142(19890801)64:3<629::AID-CNCR2820640311>3.0.CO
[8] 2-L
[9] 2ND MALIGNANCIES FROM ADJUVANT CHEMOTHERAPY - TOO SOON TO TELL
HENDERSON, IC
GELMAN, R
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) : 1135 - 1137
[10] EFFICACY OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY
MANSOUR, EG
GRAY, R
SHATILA, AH
OSBORNE, CK
TORMEY, DC
GILCHRIST, KW
COOPER, MR
FALKSON, G
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) : 485 - 490